Compounded with
Semaglutide
First-party weight-management formulary lists Semaglutide/Pyridoxine.
Tirzepatide
First-party weight-management formulary lists Tirzepatide/Pyridoxine.
Product evidence does not establish current availability.
Pharmacy evidence record · researched 2026-08-20
Promise Pharmacy
Promise Pharmacy LLC
8 citations5 action records6 explicit unknowns
Locations in the source record
- 31818 US Highway 19 N, Palm Harbor, FL 34684
Services named by sources
- 503A patient-specific sterile and nonsterile compounding
- Weight management
- Hormone health
- Anti-aging
- Dermatology
- Peptides
- Clinic/telehealth fulfillment
- White-label and kitting
Regulatory compliance
503 pathway evidence
A pathway label describes which federal rules apply — it is not a quality claim.
Section 503A
Source-backed pathway evidence
verified first party and fda
Section 503B
Not conclusively established
not found in current fda registry check
Telehealth providers
No provider relationship is verified in the bound sources.
Clinic Scout links a provider only when an explicit source names the relationship.
Regulatory history
Actions stay dated and bounded.
FDA warning/recall/state-referral/Form 483/current-503B and Florida license sources were checked. FDA actions and Florida discipline/complaint flags were verified; Florida detail-tab terms remain unresolved and are not softened or inferred.
U.S. Food and Drug Administration · 2018-10-22
Voluntary recall acknowledged by FDA
Recall of prednisolone/gatifloxacin ophthalmic solution after small particulates were observed.
Status not statedU.S. Food and Drug Administration · 2018-12-13
Voluntary recall acknowledged by FDA
Recall of non-hazardous sterile products within expiry due to lack of sterility assurance.
Status not statedU.S. Food and Drug Administration · 2019-07-29
Warning Letter
FDA stated that products failed section 503A conditions, sterile drugs were prepared under insanitary conditions, distributed ophthalmic products contained particulates, and an injectable product exceeded label strength.
Status not statedU.S. Food and Drug Administration · 2022-07-27
State referral letter
Following an August-September 2021 inspection, FDA referred poor aseptic-practice concerns for state follow-up, stated that FDA did not intend further action at that time, and said corrective actions could be overseen by the state.
Status not statedFlorida Board of Pharmacy / Department of Health · date not stated
Discipline and public complaint flags
The current license page explicitly shows Discipline on File: Yes and Public Complaint: Yes. The linked detail-tab records were not extractable, so no disposition, penalty, case number or date is asserted.
Status not statedWhat remains unverified
- Complete 42-state license list
- Individual non-Florida license numbers/statuses
- Current Florida license status text
- Florida discipline/admin-action details
- Florida public-complaint details
- Current sterile-production status after 2022 referral
Patient reviews
Share your experience for moderationNo Clinic Scout patient reviews are published for this pharmacy. Submissions go through manual moderation before anything appears here.
What this record verifies for you
7 evidence dimensions carry dated, source-backed verification.
Each line traces to a citation in the source list below — read the exact captured wording before relying on it.
- dated source ledger: 8 first-party/regulator citations with URL, accessed date, and exact supporting quote.
- legal entity provenance: Legal entity recorded as Promise Pharmacy LLC with status verified_fda_and_state_board.
- regulator verified state evidence: 1 regulator-verified state record(s) preserved with field-level provenance.
- regulatory action timeline: 5 dated regulatory/action record(s) with bounded summaries and regulator citations.
- 503 status provenance: 503A/503B fields preserve pathway, source status, and current-versus-historical limits from the bound research.
- source bound glp relevance: GLP relevance status is verified_first_party, tied to the record citation ledger.
- transparent unknowns: 6 unresolved field(s) are explicitly named and prevented from rendering as facts.
No superiority claim is made for review volume, ratings, or patient sentiment.
Sources and exact captured wording
- first_party · accessed 2026-08-20
Promise Pharmacy is an independently owned compounding pharmacy specializing in sterile and non-sterile preparations ... Founded in 2006 and based in Palm Harbor, Florida
- first_party · accessed 2026-08-20
42 State Licenses ... 503A COMPOUNDING ... We specialize in 503A compounding, tailoring every prescription to the patient
- first_party · accessed 2026-08-20
503A Compounding ... Semaglutide/Pyridoxine (Vit B6) ... Tirzepatide/Pyridoxine (Vit B6)
- fda · accessed 2026-08-20
The investigator noted serious deficiencies in your practices for producing sterile drug products, which put patients at risk ... drug products intended or expected to be sterile were prepared, packed, or held under insanitary conditions
- fda · accessed 2026-08-20
voluntarily recall prednisolone and gatifloxacin ophthalmic solutions due to small particulates floating in the solutions ... recall all non-hazardous drug products intended to be sterile within expiry due to lack of sterility assurance
- fda · accessed 2026-08-20
FDA does not intend to take further action at this time with regard to the findings of this inspection ... FDA is referring this matter to you for follow up to ensure appropriate corrective action has been taken.
- state_board · accessed 2026-08-20
PROMISE PHARMACY LLC License Number: PH29090 ... License Expiration Date 2/28/2027 ... Discipline on File Yes ... Public Complaint Yes
- fda · accessed 2026-08-20
Updated as of 8/18/2026 ... This table lists the outsourcing facilities that have submitted registration information that has been determined to be complete by the data lock date for the latest weekly update of the table.
Questions readers ask
Is Promise Pharmacy legit?
GLP Clinic Scout does not issue a blanket legitimacy verdict. This research record preserves 8 dated first-party or regulator citation(s), 5 regulatory/action record(s), and 6 explicitly unresolved field(s). Review the cited evidence and current license status before making a decision.